<![CDATA[dendreon Resources | BNET]]> en-us <![CDATA[Dendreon's New Stock Offering Takes Advantage of Provenge Decision Uncertainty]]> Wed, 09 Dec 2009 09:34:27 -0800 <![CDATA[Dendreon's Provenge Beats FDA Approval Standard By Just Half a Percent; Stock Plunges Before Rally]]> Tue, 28 Apr 2009 14:54:13 -0700 <![CDATA[Dendreon Still Faces Hurdles for Provenge Despite Positive Phase 3 Data]]> Wed, 15 Apr 2009 07:55:53 -0700 <![CDATA[Dendreon Gets Another Analyst Thumbs-Down]]> Fri, 17 Oct 2008 12:56:36 -0700 DNDN DNDN <![CDATA[Dendreon: Pro-Provenge Activists Heap Abuse on Cancer Drug’s Critics]]> Tue, 07 Oct 2008 08:59:00 -0700 <![CDATA[Dendreon: Pro-Provenge Activists Heap Abuse on Cancer Drug’s Critics]]> Tue, 07 Oct 2008 08:19:15 -0700 <![CDATA[Vultures Circle Dendreon Even Though Jury Is Still Out on Provenge]]> Fri, 15 Aug 2008 16:46:23 -0700 <![CDATA[Seattle-Based Biotechnology Firm Dendreon Strikes Gold with CEO.]]> Mon, 29 Mar 2004 23:59:59 -0800 <![CDATA[Dendreon To Acquire Corvas; New Company Will Have Multiple Clinical Products, Significant Oncology R&D Pipeline, Strong Cash Position and Experienced Management Team]]> Tue, 25 Feb 2003 23:59:59 -0800 <![CDATA[Cancer-Drug Report Gives Good News to Seattle-Based Biotech Firm Dendreon.]]> Sat, 10 Aug 2002 23:59:59 -0700 <![CDATA[Biotech leader pleads his sector's special case.]]> Wed, 20 Feb 2002 23:59:59 -0800 NDAQ NDAQ